Lastly, the AUC of the combination of miR-124-3p and ANGPTL2 for predicting nonobese PCOS patients was 0.889, the specificity was 83.82%, and the sensitivity was 83.33% (Figure 1(e)). This evidence concerns the gene ANGPTL2 and polycystic ovary syndrome.